MAHLY
Price
$18.34
Change
+$0.84 (+4.80%)
Updated
Sep 15 closing price
Capitalization
3.62B
ZYXI
Price
$1.45
Change
-$0.02 (-1.36%)
Updated
Sep 26 closing price
Capitalization
43.93M
25 days until earnings call
Interact to see
Advertisement

MAHLY vs ZYXI

Header iconMAHLY vs ZYXI Comparison
Open Charts MAHLY vs ZYXIBanner chart's image
Medipal Holdings
Price$18.34
Change+$0.84 (+4.80%)
Volume$146
Capitalization3.62B
Zynex
Price$1.45
Change-$0.02 (-1.36%)
Volume$54.69K
Capitalization43.93M
MAHLY vs ZYXI Comparison Chart in %
Loading...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. ZYXI commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAHLY is a Buy and ZYXI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (MAHLY: $18.34 vs. ZYXI: $1.45)
Brand notoriety: MAHLY and ZYXI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 44% vs. ZYXI: 19%
Market capitalization -- MAHLY: $3.62B vs. ZYXI: $43.93M
MAHLY [@Medical Distributors] is valued at $3.62B. ZYXI’s [@Medical Distributors] market capitalization is $43.93M. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 0 FA rating(s) are green whileZYXI’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 0 green, 5 red.
  • ZYXI’s FA Score: 0 green, 5 red.
According to our system of comparison, MAHLY is a better buy in the long-term than ZYXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 3 TA indicator(s) are bullish while ZYXI’s TA Score has 2 bullish TA indicator(s).

  • MAHLY’s TA Score: 3 bullish, 2 bearish.
  • ZYXI’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, both MAHLY and ZYXI are a good buy in the short-term.

Price Growth

MAHLY (@Medical Distributors) experienced а 0.00% price change this week, while ZYXI (@Medical Distributors) price change was -6.45% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Reported Earning Dates

ZYXI is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.62B) has a higher market cap than ZYXI($43.9M). ZYXI has higher P/E ratio than MAHLY: ZYXI (24.78) vs MAHLY (14.12). MAHLY YTD gains are higher at: 14.090 vs. ZYXI (-81.898). MAHLY has higher annual earnings (EBITDA): 100B vs. ZYXI (-15.49M). MAHLY has more cash in the bank: 251B vs. ZYXI (17.5M). MAHLY has higher revenues than ZYXI: MAHLY (3.6T) vs ZYXI (145M).
MAHLYZYXIMAHLY / ZYXI
Capitalization3.62B43.9M8,244%
EBITDA100B-15.49M-645,703%
Gain YTD14.090-81.898-17%
P/E Ratio14.1224.7857%
Revenue3.6T145M2,485,517%
Total Cash251B17.5M1,434,286%
Total DebtN/A72.5M-
FUNDAMENTALS RATINGS
MAHLY vs ZYXI: Fundamental Ratings
MAHLY
ZYXI
OUTLOOK RATING
1..100
5011
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
5299
PRICE GROWTH RATING
1..100
4995
P/E GROWTH RATING
1..100
4590
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MAHLY's Valuation (91) in the null industry is in the same range as ZYXI (97) in the Medical Specialties industry. This means that MAHLY’s stock grew similarly to ZYXI’s over the last 12 months.

MAHLY's Profit vs Risk Rating (87) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that MAHLY’s stock grew similarly to ZYXI’s over the last 12 months.

MAHLY's SMR Rating (52) in the null industry is somewhat better than the same rating for ZYXI (99) in the Medical Specialties industry. This means that MAHLY’s stock grew somewhat faster than ZYXI’s over the last 12 months.

MAHLY's Price Growth Rating (49) in the null industry is somewhat better than the same rating for ZYXI (95) in the Medical Specialties industry. This means that MAHLY’s stock grew somewhat faster than ZYXI’s over the last 12 months.

MAHLY's P/E Growth Rating (45) in the null industry is somewhat better than the same rating for ZYXI (90) in the Medical Specialties industry. This means that MAHLY’s stock grew somewhat faster than ZYXI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYZYXI
RSI
ODDS (%)
Bearish Trend 3 days ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
39%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
44%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
28%
Bullish Trend 7 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
30%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BODI5.970.07
+1.19%
The Beachbody Company Inc
PWP21.410.19
+0.90%
Perella Weinberg Partners
T28.310.01
+0.04%
AT&T
RYTM99.160.02
+0.02%
Rhythm Pharmaceuticals
GRAF10.54-0.02
-0.19%
Graf Global Corp

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and MEPDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
MEPDF - MAHLY
9%
Poorly correlated
N/A
ZYXI - MAHLY
5%
Poorly correlated
-1.36%
ARRJF - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
NSVGF - MAHLY
2%
Poorly correlated
N/A
More

ZYXI and

Correlation & Price change

A.I.dvisor tells us that ZYXI and HSIC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and HSIC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYXI
1D Price
Change %
ZYXI100%
-1.36%
HSIC - ZYXI
24%
Poorly correlated
+0.64%
OMI - ZYXI
16%
Poorly correlated
-1.45%
EDAP - ZYXI
9%
Poorly correlated
-3.97%
SHTDF - ZYXI
9%
Poorly correlated
-4.46%
COSM - ZYXI
8%
Poorly correlated
-0.92%
More